Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Paleolithic diet during pregnancy-A potential beneficial effect on metabolic indices and birth weight.

Lavie M, Lavie I, Maslovitz S.

Eur J Obstet Gynecol Reprod Biol. 2019 Aug 31;242:7-11. doi: 10.1016/j.ejogrb.2019.08.013. [Epub ahead of print]

PMID:
31522093
2.

Reply to Shoemark et al., and Shapiro et al.

Amirav I, Lavie M.

Am J Respir Crit Care Med. 2019 Aug 21. doi: 10.1164/rccm.201907-1489LE. [Epub ahead of print] No abstract available.

PMID:
31433954
3.

Rethink Respiratory Rate for Diagnosing Childhood Pneumonia.

Amirav I, Lavie M.

EClinicalMedicine. 2019 Jun 27;12:6-7. doi: 10.1016/j.eclinm.2019.06.013. eCollection 2019 Jul. No abstract available.

4.

Role of the cytosolic domain of occludin in trafficking and hepatitis C virus infection.

Lavie M, Linna L, Moustafa RI, Belouzard S, Fukasawa M, Dubuisson J.

Traffic. 2019 Oct;20(10):753-773. doi: 10.1111/tra.12680. Epub 2019 Aug 11.

PMID:
31328852
5.

In Defense of High-Speed Video Microscopy in Evaluating Patients with Suspected Primary Ciliary Dyskinesia.

Lavie M, Amirav I.

Am J Respir Crit Care Med. 2019 Jun 28. doi: 10.1164/rccm.201904-0773LE. [Epub ahead of print] No abstract available.

PMID:
31251674
6.

Dehydrojuncusol, a Natural Phenanthrene Compound Extracted from Juncus maritimus, Is a New Inhibitor of Hepatitis C Virus RNA Replication.

Sahuc ME, Sahli R, Rivière C, Pène V, Lavie M, Vandeputte A, Brodin P, Rosenberg AR, Dubuisson J, Ksouri R, Rouillé Y, Sahpaz S, Séron K.

J Virol. 2019 May 1;93(10). pii: e02009-18. doi: 10.1128/JVI.02009-18. Print 2019 May 15.

PMID:
30842319
7.

Functional Study of the C-Terminal Part of the Hepatitis C Virus E1 Ectodomain.

Moustafa RI, Haddad JG, Linna L, Hanoulle X, Descamps V, Mesalam AA, Baumert TF, Duverlie G, Meuleman P, Dubuisson J, Lavie M.

J Virol. 2018 Sep 26;92(20). pii: e00939-18. doi: 10.1128/JVI.00939-18. Print 2018 Oct 15.

8.

The Value of Measuring Inspiratory Capacity in Subjects With Cystic Fibrosis.

Vilozni D, Dagan A, Lavie M, Sarouk I, Bar-Aluma BE, Ashkenazi M, Mendelovich SL, Betzalel Y, Efrati O.

Respir Care. 2018 Aug;63(8):981-987. doi: 10.4187/respcare.05920. Epub 2018 Jul 17.

9.

Glycan Shielding and Modulation of Hepatitis C Virus Neutralizing Antibodies.

Lavie M, Hanoulle X, Dubuisson J.

Front Immunol. 2018 Apr 27;9:910. doi: 10.3389/fimmu.2018.00910. eCollection 2018. Review.

10.

Ivacaftor for the p.Ser549Arg (S549R) gating mutation - The Israeli experience.

Dagan A, Cohen-Cymberknoh M, Shteinberg M, Levine H, Vilozni D, Bezalel Y, Bar Aluma BE, Sarouk I, Ashkenazi M, Lavie M, Tsabari R, Blau H, Kerem E, Bentur L, Efrati O, Livnat G.

Respir Med. 2017 Oct;131:225-228. doi: 10.1016/j.rmed.2017.08.026. Epub 2017 Sep 1.

PMID:
28947035
11.

Interplay between hepatitis C virus and lipid metabolism during virus entry and assembly.

Lavie M, Dubuisson J.

Biochimie. 2017 Oct;141:62-69. doi: 10.1016/j.biochi.2017.06.009. Epub 2017 Jun 16. Review.

PMID:
28630011
12.

Identification of Novel Functions for Hepatitis C Virus Envelope Glycoprotein E1 in Virus Entry and Assembly.

Haddad JG, Rouillé Y, Hanoulle X, Descamps V, Hamze M, Dabboussi F, Baumert TF, Duverlie G, Lavie M, Dubuisson J.

J Virol. 2017 Mar 29;91(8). pii: e00048-17. doi: 10.1128/JVI.00048-17. Print 2017 Apr 15.

13.

Recombinant Parvoviruses Armed to Deliver CXCL4L1 and CXCL10 Are Impaired in Their Antiangiogenic and Antitumoral Effects in a Kaposi Sarcoma Tumor Model Due To the Chemokines' Interference with the Virus Cycle.

Dinsart C, Pervolaraki K, Stroh-Dege A, Lavie M, Ronsse I, Rommelaere J, Van Damme J, Van Raemdonck K, Struyf S.

Hum Gene Ther. 2017 Mar;28(3):295-306. doi: 10.1089/hum.2016.108. Epub 2016 Dec 29.

PMID:
28042949
14.

Collecting clinical data in primary ciliary dyskinesia- challenges and opportunities.

Amirav I, Roduta Roberts M, Mussaffi H, Mandelberg A, Roth Y, Abitbul R, Luder A, Blau H, Alkrinawi S, Aviram M, Ben-Ami M, Rotschild M, Bentur L, Shoseyov D, Cohen-Cymberknoh M, Kerem E, Avital A, Springer C, Hevroni A, Dabbah H, Elizur A, Picard E, Goldberg S, Rivlin J, Livnat G, Lavie M, Alias N, Soferman R, Olbrich H, Raidt J, Wallmeier J, Werner C, Loges NT, Omran H.

Version 2. F1000Res. 2016 Aug 18 [revised 2016 Jan 1];5:2031. eCollection 2016.

15.

Primary ciliary dyskinesia in Israel: Prevalence, clinical features, current diagnosis and management practices.

Abitbul R, Amirav I, Blau H, Alkrinawi S, Aviram M, Shoseyov D, Bentur L, Avital A, Springer C, Lavie M, Prais D, Dabbah H, Elias N, Elizur A, Goldberg S, Hevroni A, Kerem E, Luder A, Roth Y, Cohen-Cymberknoh M, Ben Ami M, Mandelberg A, Livnat G, Picard E, Rivlin J, Rotschild M, Soferman R, Loges NT, Olbrich H, Werner C, Wolter A, Herting M, Wallmeier J, Raidt J, Omran H, Mussaffi H.

Respir Med. 2016 Oct;119:41-47. doi: 10.1016/j.rmed.2016.08.015. Epub 2016 Aug 23.

16.

Identification of a New Benzimidazole Derivative as an Antiviral against Hepatitis C Virus.

Vausselin T, Séron K, Lavie M, Mesalam AA, Lemasson M, Belouzard S, Fénéant L, Danneels A, Rouillé Y, Cocquerel L, Foquet L, Rosenberg AR, Wychowski C, Meuleman P, Melnyk P, Dubuisson J.

J Virol. 2016 Sep 12;90(19):8422-34. doi: 10.1128/JVI.00404-16. Print 2016 Oct 1.

17.

Consequences of Expiratory Flow Limitation at Rest in Subjects with Cystic Fibrosis.

Vilozni D, Lavie M, Ofek M, Sarouk I, Bar-Aluma BE, Dagan A, Ashkenazi M, Segel MJ, Efrati O.

Ann Am Thorac Soc. 2016 Jun;13(6):825-32. doi: 10.1513/AnnalsATS.201508-485OC.

PMID:
27219817
18.

Systematic Analysis of CCNO Variants in a Defined Population: Implications for Clinical Phenotype and Differential Diagnosis.

Amirav I, Wallmeier J, Loges NT, Menchen T, Pennekamp P, Mussaffi H, Abitbul R, Avital A, Bentur L, Dougherty GW, Nael E, Lavie M, Olbrich H, Werner C, Kintner C, Omran H; Israeli PCD Consortium Investigators.

Hum Mutat. 2016 Apr;37(4):396-405. doi: 10.1002/humu.22957. Epub 2016 Feb 4.

PMID:
26777464
19.

Glucose intolerance in cystic fibrosis as a determinant of pulmonary function and clinical status.

Lavie M, Fisher D, Vilozni D, Forschmidt R, Sarouk I, Kanety H, Hemi R, Efrati O, Modan-Moses D.

Diabetes Res Clin Pract. 2015 Dec;110(3):276-84. doi: 10.1016/j.diabres.2015.10.007. Epub 2015 Oct 14.

PMID:
26508676
20.

The impact of a national population carrier screening program on cystic fibrosis birth rate and age at diagnosis: Implications for newborn screening.

Stafler P, Mei-Zahav M, Wilschanski M, Mussaffi H, Efrati O, Lavie M, Shoseyov D, Cohen-Cymberknoh M, Gur M, Bentur L, Livnat G, Aviram M, Alkrinawi S, Picard E, Prais D, Steuer G, Inbar O, Kerem E, Blau H.

J Cyst Fibros. 2016 Jul;15(4):460-6. doi: 10.1016/j.jcf.2015.08.007. Epub 2015 Sep 16.

21.

The Short-Term Effect of Breathing Tasks Via an Incentive Spirometer on Lung Function Compared With Autogenic Drainage in Subjects With Cystic Fibrosis.

Sokol G, Vilozni D, Hakimi R, Lavie M, Sarouk I, Bat-El Bar, Dagan A, Ofek M, Efrati O.

Respir Care. 2015 Dec;60(12):1819-25. doi: 10.4187/respcare.04008. Epub 2015 Sep 15.

22.

Cough ability measurements and recurrent respiratory symptoms in individuals with Ataxia Telangiectasia.

Vilozni D, Lavie M, Sarouk I, Levi Y, Alcaneses Ofek MR, Efrati O.

J Asthma. 2016;53(1):37-42. doi: 10.3109/02770903.2015.1032304. Epub 2015 Sep 12.

PMID:
26364772
23.

[CHRONIC MYELOID LEUKEMIA IN A YOUNG MALE PRESENTING WITH BILATERAL CALF PAIN DUE TO LEUKOSTASIS].

Rottenstreich M, Lavie M, Rottenstreich A.

Harefuah. 2015 May;154(5):296-8, 340. Hebrew.

PMID:
26168638
24.

Nocardia Colonization: A Risk Factor for Lung Deterioration in Cystic Fibrosis Patients?

Dagan A, Keller N, Vilozni D, Ramon-Saraf R, Bar BE, Sarouk I, Ashkenazi M, Lavie M, Efrati O.

Med Sci Monit. 2015 Jun 30;21:1889-94. doi: 10.12659/MSM.893643.

25.

FVC deterioration, airway obstruction determination, and life span in Ataxia telangiectasia.

Vilozni D, Lavie M, Sarouk I, Bar-Aluma BE, Dagan A, Ashkenazi M, Ofek M, Efrati O.

Respir Med. 2015 Jul;109(7):890-6. doi: 10.1016/j.rmed.2015.05.013. Epub 2015 May 21.

26.

Long-term follow-up of distal intestinal obstruction syndrome in cystic fibrosis.

Lavie M, Manovitz T, Vilozni D, Levy-Mendelovich S, Sarouk I, Weintraubv I, Shoseyov D, Cohen-Cymberknoh M, Rivlin J, Efrati O.

World J Gastroenterol. 2015 Jan 7;21(1):318-25. doi: 10.3748/wjg.v21.i1.318.

27.

Several siblings with Cystic Fibrosis as a risk factor for poor outcome.

Lavie M, Shemer O, Sarouk I, Bar Aluma Be, Dagan A, Efrati O, Vilozni D.

Respir Med. 2015 Jan;109(1):74-8. doi: 10.1016/j.rmed.2014.11.012. Epub 2014 Dec 9.

28.

Cough characteristics and FVC maneuver in cystic fibrosis.

Vilozni D, Lavie M, Ofek M, Sarouk I, Efrati O.

Respir Care. 2014 Dec;59(12):1912-7. doi: 10.4187/respcare.03290. Epub 2014 Sep 23.

29.

Identification of conserved residues in hepatitis C virus envelope glycoprotein E2 that modulate virus dependence on CD81 and SRB1 entry factors.

Lavie M, Sarrazin S, Montserret R, Descamps V, Baumert TF, Duverlie G, Séron K, Penin F, Dubuisson J.

J Virol. 2014 Sep;88(18):10584-97. doi: 10.1128/JVI.01402-14. Epub 2014 Jul 2.

30.

Capacity of wild-type and chemokine-armed parvovirus H-1PV for inhibiting neo-angiogenesis.

Lavie M, Struyf S, Stroh-Dege A, Rommelaere J, Van Damme J, Dinsart C.

Virology. 2013 Dec;447(1-2):221-32. doi: 10.1016/j.virol.2013.09.019. Epub 2013 Oct 4.

31.

Modeling of cognitive impairment by disease duration in multiple sclerosis: a cross-sectional study.

Achiron A, Chapman J, Magalashvili D, Dolev M, Lavie M, Bercovich E, Polliack M, Doniger GM, Stern Y, Khilkevich O, Menascu S, Hararai G, Gurevich M, Barak Y.

PLoS One. 2013 Aug 1;8(8):e71058. doi: 10.1371/journal.pone.0071058. Print 2013.

32.

Antitumoral activity of parvovirus-mediated IL-2 and MCP-3/CCL7 delivery into human pancreatic cancer: implication of leucocyte recruitment.

Dempe S, Lavie M, Struyf S, Bhat R, Verbeke H, Paschek S, Berghmans N, Geibig R, Rommelaere J, Van Damme J, Dinsart C.

Cancer Immunol Immunother. 2012 Nov;61(11):2113-23. doi: 10.1007/s00262-012-1279-4. Epub 2012 May 11.

PMID:
22576056
33.

Progressive flow-to-volume dysanapsis in cystic fibrosis: a predictor for lung transplantation?

Vilozni D, Lavie M, Sarouk I, Efrati O.

Am J Respir Crit Care Med. 2012 Jul 1;186(1):82-7. doi: 10.1164/rccm.201202-0272OC. Epub 2012 Apr 26.

PMID:
22538801
34.

IV Penicillin G is as effective as IV cefuroxime in treating community-acquired pneumonia in children.

Amarilyo G, Glatstein M, Alper A, Scolnik D, Lavie M, Schneebaum N, Grisaru-Soen G, Assia A, Ben-Sira L, Reif S.

Am J Ther. 2014 Mar-Apr;21(2):81-4. doi: 10.1097/MJT.0b013e3182459c28.

PMID:
22407197
35.

Hospital versus home treatment of respiratory exacerbations in cystic fibrosis.

Lavie M, Vilozni D, Sokol G, Somech R, Szeinberg A, Efrati O.

Med Sci Monit. 2011 Dec;17(12):CR698-703.

36.

Cellular and clinical report of new Griscelli syndrome type III cases.

Westbroek W, Klar A, Cullinane AR, Ziegler SG, Hurvitz H, Ganem A, Wilson K, Dorward H, Huizing M, Tamimi H, Vainshtein I, Berkun Y, Lavie M, Gahl WA, Anikster Y.

Pigment Cell Melanoma Res. 2012 Jan;25(1):47-56. doi: 10.1111/j.1755-148X.2011.00901.x. Epub 2011 Oct 3.

37.

HCV Glycoproteins: Assembly of a Functional E1–E2 Heterodimer.

Lavie M, Goffard A, Dubuisson J.

In: Tan SL, editor. Hepatitis C Viruses: Genomes and Molecular Biology. Norfolk (UK): Horizon Bioscience; 2006. Chapter 4.

38.

Fertility in women after surgical treatment of nonepithelial ovarian tumors.

Benshushan A, Ben-Shachar I, Lavie M, Mejia-Gomez J, Kogan L, Shushan A.

Fertil Steril. 2010 Dec;94(7):2786-8. doi: 10.1016/j.fertnstert.2010.05.060. Epub 2010 Aug 2.

PMID:
20673891
39.

The association of CD81 with tetraspanin-enriched microdomains is not essential for Hepatitis C virus entry.

Rocha-Perugini V, Lavie M, Delgrange D, Canton J, Pillez A, Potel J, Lecoeur C, Rubinstein E, Dubuisson J, Wychowski C, Cocquerel L.

BMC Microbiol. 2009 May 28;9:111. doi: 10.1186/1471-2180-9-111.

40.

Single dose of methylphenidate improves cognitive performance in multiple sclerosis patients with impaired attention process.

Harel Y, Appleboim N, Lavie M, Achiron A.

J Neurol Sci. 2009 Jan 15;276(1-2):38-40. doi: 10.1016/j.jns.2008.08.025. Epub 2008 Sep 24.

PMID:
18817930
41.

Ceramide enrichment of the plasma membrane induces CD81 internalization and inhibits hepatitis C virus entry.

Voisset C, Lavie M, Helle F, Op De Beeck A, Bilheu A, Bertrand-Michel J, Tercé F, Cocquerel L, Wychowski C, Vu-Dac N, Dubuisson J.

Cell Microbiol. 2008 Mar;10(3):606-17. Epub 2007 Nov 2.

PMID:
17979982
42.

Prolonged response times characterize cognitive performance in multiple sclerosis.

Achiron A, Doniger GM, Harel Y, Appleboim-Gavish N, Lavie M, Simon ES.

Eur J Neurol. 2007 Oct;14(10):1102-8.

PMID:
17880565
43.

Assembly of a functional HCV glycoprotein heterodimer.

Lavie M, Goffard A, Dubuisson J.

Curr Issues Mol Biol. 2007 Jul;9(2):71-86. Review.

44.

Serum amyloid A has antiviral activity against hepatitis C virus by inhibiting virus entry in a cell culture system.

Lavie M, Voisset C, Vu-Dac N, Zurawski V, Duverlie G, Wychowski C, Dubuisson J.

Hepatology. 2006 Dec;44(6):1626-34.

PMID:
17133472
45.

[Tumescent local anaesthesia for mastectomy: lidocaine plasma concentration].

Sleth JC, Lavie M, Mion P, Saizy C, Servais R.

Ann Fr Anesth Reanim. 2006 Jan;25(1):74-6. Epub 2005 Oct 26. French. No abstract available.

PMID:
16256296
46.

Cognitive patterns and progression in multiple sclerosis: construction and validation of percentile curves.

Achiron A, Polliack M, Rao SM, Barak Y, Lavie M, Appelboim N, Harel Y.

J Neurol Neurosurg Psychiatry. 2005 May;76(5):744-9.

47.

Intravenous immunoglobulin treatment following the first demyelinating event suggestive of multiple sclerosis: a randomized, double-blind, placebo-controlled trial.

Achiron A, Kishner I, Sarova-Pinhas I, Raz H, Faibel M, Stern Y, Lavie M, Gurevich M, Dolev M, Magalashvili D, Barak Y.

Arch Neurol. 2004 Oct;61(10):1515-20.

PMID:
15477504
48.

T cell vaccination in multiple sclerosis relapsing-remitting nonresponders patients.

Achiron A, Lavie G, Kishner I, Stern Y, Sarova-Pinhas I, Ben-Aharon T, Barak Y, Raz H, Lavie M, Barliya T, Faibel M, Cohen IR, Mandel M.

Clin Immunol. 2004 Nov;113(2):155-60.

PMID:
15451472
49.
50.

Screening for early cognitive impairment in multiple sclerosis patients using the clock drawing test.

Barak Y, Lavie M, Achiron A.

J Clin Neurosci. 2002 Nov;9(6):629-32.

PMID:
12604271

Supplemental Content

Support Center